The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase

被引:165
|
作者
Cooper, CE
Lynagh, GR
Hoyes, KP
Hider, RC
Cammack, R
Porter, JB
机构
[1] UCL, SCH MED, DEPT HAEMATOL, LONDON WC1E 6HX, ENGLAND
[2] UNIV LONDON KINGS COLL, DIV LIFE SCI, MET BIOL & MED CTR, LONDON W8 7AH, ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1074/jbc.271.34.20291
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The depletion of cellular iron can lead to the inhibition of ribonucleotide reductase, preventing new DNA synthesis and hence inhibiting cell proliferation. Electron paramagnetic resonance (EPR) spectroscopy has been used to examine simultaneously for the first time the relationship between chelation of intracellular iron and the rate of removal and regeneration of the tyrosyl radical of ribonucleotide reductase within intact human leukemia K562 cells. The different physiochemical characteristics of relatively hydrophobic low molecular weight bidentate hydroxypyridinone chelators and the higher molecular weight hexadentate ferrioxamine have been exploited to elucidate these interactions further. The base-line concentration of EPR detectable mononuclear nonheme iron complexes was 3.15 +/- 1.05 mu M, rising on incubation with chelators more rapidly with hydroxypyridinones than with desferrioxamine. Hydroxypyridinones also removed the tyrosyl radical more rapidly, apparently as a consequence of depletion of the intracellular iron pools necessary to regenerate the active enzyme and compatible with their reportedly greater cell toxicity. The radical decay rate is consistent with previous models, suggesting that iron is spontaneously removed from mammalian ribonucleotide reductase. Upon removal of extracellular chelator the regeneration of the tyrosyl radical was significantly faster for hydroxypyridinones than for desferrioxamine, consistent with their differential effects on cell cycle synchronization.
引用
收藏
页码:20291 / 20299
页数:9
相关论文
共 50 条
  • [41] EFFECTS OF IRON, COPPER AND ZINC ON THE ACTIVITY OF RIBONUCLEOTIDE REDUCTASE IN NORMAL AND LEUKEMIC HUMAN-LYMPHOCYTES
    OBLENDER, M
    CARPENTIERI, U
    ANTICANCER RESEARCH, 1990, 10 (01) : 123 - 127
  • [42] Direct inhibition of ribonucleotide reductase in human T lymphocytes by phenolic components of cigarette tar.
    McCue, JM
    Link, KL
    Eaton, SS
    Freed, BM
    FASEB JOURNAL, 2000, 14 (06): : A929 - A929
  • [43] THE IRON CENTER IN RIBONUCLEOTIDE REDUCTASE FROM ESCHERICHIA-COLI
    PETERSSON, L
    GRASLUND, A
    EHRENBERG, A
    SJOBERG, BM
    REICHARD, P
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1980, 255 (14) : 6706 - 6712
  • [44] Ribonucleotide reductase inhibitors with erythropoietin and iron sulfate against malaria
    Saei, Amir Ata
    Ahmadian, Somaieh
    MEDICAL HYPOTHESES, 2009, 72 (05) : 611 - 611
  • [45] Modeling inhibition of ribonucleotide reductase by 2-substituted hexofuranoses
    Mudgal, Mukesh M.
    Wnuk, Stanislaw F.
    Robins, Morris J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [47] SPECIFIC-INHIBITION OF HERPESVIRUS RIBONUCLEOTIDE REDUCTASE BY SYNTHETIC PEPTIDES
    DUTIA, BM
    FRAME, MC
    SUBAKSHARPE, JH
    CLARK, WN
    MARSDEN, HS
    NATURE, 1986, 321 (6068) : 439 - 441
  • [48] INHIBITION OF RIBONUCLEOTIDE REDUCTASE IN THYMOCYTES OF RATS TREATED BY DITIOCARB SODIUM
    TEMPEL, K
    SPATH, A
    STAMMBERGER, I
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1990, 40-2 (07): : 787 - 790
  • [49] EXAFS STUDIES OF BINUCLEAR IRON PROTEINS - HEMERYTHRIN AND RIBONUCLEOTIDE REDUCTASE
    SCARROW, RC
    MARONEY, MJ
    PALMER, SM
    QUE, L
    ROE, AL
    SALOWE, SP
    STUBBE, J
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1987, 109 (25) : 7857 - 7864
  • [50] Formation and reactions of the iron tyrosyl radical site in ribonucleotide reductase
    Gräslund, A
    JOURNAL OF INORGANIC BIOCHEMISTRY, 1999, 74 (1-4) : 26 - 26